
Scientific Health Development
8144 Walnut Hill Ln., Suite 905, Dallas, TX, 75231, United States
Overview
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Urologic Health | May 2026Participated | $11 MSeed | |
Cooler Heads | Jul 2025Participated | $11 MSeries A | |
SecondWave Systems | Apr 2025Participated | $7 MSeries A | |
Liberate Medical | Jul 2023Led | $6 MSeries B | |
Podimetrics | Mar 2022Participated | $45 MSeries C | |
Koya Medical | Feb 2022Participated | $26 MSeries B | |
MiNDERA Corporation | May 2021Led | $13 MSeries A | |
Koya Medical | Jan 2021Participated | $11 MSeries A | |
Podimetrics | Aug 2020Participated | $3 MSeries B | |
Procyrion | Jul 2019Participated | $30 MSeries D | |
Podimetrics | May 2019Participated | $13 MSeries B | |
Procyrion | Jan 2018Participated | $16 MSeries C | |
Urologic Health | May 2026Participated | $11 MSeed | |
Cooler Heads | Jul 2025Participated | $11 MSeries A | |
SecondWave Systems | Apr 2025Participated | $7 MSeries A | |
Liberate Medical | Jul 2023Led | $6 MSeries B | |
Podimetrics | Mar 2022Participated | $45 MSeries C | |
Koya Medical | Feb 2022Participated | $26 MSeries B | |
MiNDERA Corporation | May 2021Led | $13 MSeries A | |
Koya Medical | Jan 2021Participated | $11 MSeries A | |
Podimetrics | Aug 2020Participated | $3 MSeries B | |
Procyrion | Jul 2019Participated | $30 MSeries D | |
Podimetrics | May 2019Participated | $13 MSeries B | |
Procyrion | Jan 2018Participated | $16 MSeries C |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 1 | 1 |
| Series A | 1 | 3 |
| Series B | 2 | 5 |
| Series C+ | 0 | 5 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| May '13 | 1 |
| Jun '13 | 0 |
| Jul '13 | 0 |
| Aug '13 | 0 |
| Sep '13 | 0 |
| Oct '13 | 0 |
| Nov '13 | 0 |
| Dec '13 | 0 |
| Jan '14 | 0 |
| Feb '14 | 0 |
| Mar '14 | 0 |
| Apr '14 | 0 |
| May '14 | 0 |
| Jun '14 | 0 |
| Jul '14 | 0 |
| Aug '14 | 0 |
| Sep '14 | 0 |
| Oct '14 | 0 |
| Nov '14 | 0 |
| Dec '14 | 0 |
| Jan '15 | 0 |
| Feb '15 | 0 |
| Mar '15 | 0 |
| Apr '15 | 0 |
| May '15 | 0 |
| Jun '15 | 0 |
| Jul '15 | 0 |
| Aug '15 | 1 |
| Sep '15 | 0 |
| Oct '15 | 2 |
| Nov '15 | 0 |
| Dec '15 | 0 |
| Jan '16 | 0 |
| Feb '16 | 0 |
| Mar '16 | 1 |
| Apr '16 | 0 |
| May '16 | 0 |
| Jun '16 | 0 |
| Jul '16 | 0 |
| Aug '16 | 0 |
| Sep '16 | 0 |
| Oct '16 | 0 |
| Nov '16 | 0 |
| Dec '16 | 0 |
| Jan '17 | 0 |
| Feb '17 | 0 |
| Mar '17 | 0 |
| Apr '17 | 0 |
| May '17 | 0 |
| Jun '17 | 0 |
| Jul '17 | 0 |
| Aug '17 | 1 |
| Sep '17 | 0 |
| Oct '17 | 0 |
| Nov '17 | 0 |
| Dec '17 | 0 |
| Jan '18 | 1 |
| Feb '18 | 0 |
| Mar '18 | 0 |
| Apr '18 | 0 |
| May '18 | 0 |
| Jun '18 | 0 |
| Jul '18 | 0 |
| Aug '18 | 0 |
| Sep '18 | 0 |
| Oct '18 | 0 |
| Nov '18 | 0 |
| Dec '18 | 0 |
| Jan '19 | 0 |
| Feb '19 | 0 |
| Mar '19 | 0 |
| Apr '19 | 0 |
| May '19 | 1 |
| Jun '19 | 0 |
| Jul '19 | 1 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 1 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 1 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 1 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 1 |
| Mar '22 | 1 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 1 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 1 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 1 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 1 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 17 |
| Consumer & Lifestyle | 5 |
| Networks, Cloud & Communication | 3 |
| Enterprise Software | 1 |
| E-Commerce & Retail | 1 |
| Cybersecurity & Privacy | 1 |
| Professional Services | 1 |
| Data, Analytics & IT | 1 |
| Developer Tools | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 2 |
| $5M-$10M | 4 |
| $10M-$25M | 9 |
| $25M-$50M | 3 |
| $50M-$100M | 0 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 3 of 3 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 16 |
| Europe | 1 |
| Israel | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Boston Scientific | 3 |
| Fannin Partners | 3 |
| InCube Ventures | 3 |
| Aperture Venture Partners | 2 |
| Arboretum Ventures | 2 |
| Longwood Fund | 2 |
| Norwich Ventures | 2 |
| Polaris Partners | 2 |
| Rock Health Capital | 2 |
| State of Texas | 2 |
| Third Point Ventures | 2 |
| 3x5 Partners | 1 |
| Allegro Investment Fund | 1 |
| Aperture Venture Capital | 1 |
| Asahi Kasei Ventures | 1 |
| Bluebird Ventures | 1 |
| Bolt | 1 |
| Cadence Healthcare Ventures | 1 |
| California Innovation Fund | 1 |
| Crescent Ridge Partners | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 4 | 22% |
| Participating | 14 | 78% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 2 | 50% |
| Co-led | 2 | 50% |
Team
General Partner & Chief Executive Officer
Co-Founder and General Partner
Co-Founder and General Partner